Back
Inhibrx Biosciences, Inc. 10K Form
Sell
46
INBX
Inhibrx Biosciences, Inc.
Last Price:
$80.01
Seasonality Move:
-1.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INBX News And Ratings
See the #1 stock for the next 7 days that we like better than INBX
INBX Financial Statistics
Sales & Book Value
| Annual Sales: | $200K |
|---|---|
| Cash Flow: | $-33.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.54 |
| Price / Book: | 31.59 |
Profitability
| EPS (TTM): | -10.23680 |
|---|---|
| Net Income (TTM): | $-155.1M |
| Gross Margin: | $-2.1M |
| Return on Equity: | -151.49% |
| Return on Assets: | -74.88% |
Inhibrx Biosciences, Inc. Earnings Forecast
Key Inhibrx Biosciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 3 years for INBX is -1,042.50%.
-
The Selling, General & Administrative Expenses for INBX have been equal to 63,952.50% of Gross Profit Margin.
-
The Research & Development expenses have been 100,931.00% of Revenue.
-
The Interest Expense is 0.80% of Operating Income.
-
The Net Earning history of INBX is 843,786.00% of Total Revenues.
-
Per Share Earnings over the last 3 years have been positive in 1 years.
Inhibrx Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | INBX |
| Website: | inhibrx.com |
Debt
| Debt-to-Equity Ratio: | 2.9 |
|---|---|
| Current Ratio: | 4.49 |
| Quick Ratio: | 4.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 0.69 |
|---|---|
| Forward P/E Ratio: | 0 |
INBX Technical Analysis vs Fundamental Analysis
Sell
46
Inhibrx Biosciences, Inc. (INBX)
is a Sell
Is Inhibrx Biosciences, Inc. a Buy or a Sell?
-
Inhibrx Biosciences, Inc. stock is rated a SellThe current Inhibrx Biosciences, Inc. [INBX] share price is $80.36. The Score for INBX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.